Leviathan Therapeutics, Inc. — Form D

Leviathan Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-26. The offering totals $1.0M, of which $250K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-07-26
• Form: D
• Accession: 0001939408-22-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.0M
• Amount sold: $250K
• Remaining: $750K
• Investors: 1
• Date of first sale: 2022-07-22
• Revenue range: Decline to Disclose
• SEC file number: 021-453788

Issuer

• Name: Leviathan Therapeutics, Inc.
• CIK: 0001939408
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 275 SECOND AVE, WALTHAM, MA, 02451
• Phone: 6172037118

Officers, directors & promoters (4)

More

• CIK 1939408 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search